MedTrace Logo

Impact of Body Composition on Bisoprolol and Ramipril Pharmacokinetics in Patients With Chronic Heart Failure

NCT01829880 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-04-11

No results posted yet for this study

Summary

The purpose of this study is to determine if cachexia and changes in body composition influence pharmacokinetics of bisoprolol and ramipril and the accuracy of equations for renal function estimation.

Conditions

Sponsors & Collaborators

  • The University Clinic of Pulmonary and Allergic Diseases Golnik

    lead OTHER

Principal Investigators

  • Mitja Lainscak, MD, PhD · University Clinic Golnik

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-07-31
Completion
2013-08-31

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01829880 on ClinicalTrials.gov